

HY-P991307 · 1 mg
MedChemExpress · Cat: HY-P991307
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/bnd-35.htmlDescription
BND-35 is a human monoclonal antibody mAb targeting LILRB4/ILT3/CD85k. BND-35 blocks the interaction of ILT3 with APOE and fibronectin, enhances the pro-inflammatory activity of various myeloid cells, and reverses ILT3-mediated immunosuppression of T cells by various suppressive myeloid cells. BND-35 has anti-tumor activity in the hILT3 transgenic mouse tumor model.







